ArticleCancer treatment and research2023

Combining Poly (ADP-Ribose) Polymerase (PARP) Inhibitors with Chemotherapeutic Agents: Promise and Challenges.

Kyaw Zin Thein et al.PubMed ↗Publisher ↗

No numbers read from the abstract.